Doctor profile · Federal record

Dr. Refat Baridi, MD

Hematology & Oncology Physician (CMS: Medical Oncology) · Woodridge, IL

  • NPI 1285622621
  • Accepts Medicare
  • 40 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

Operates at 7 locations .

NPPES Updated May 11, 2026
Primary practice
7425 Janes Ave
Woodridge, IL 605172356
(815) 300-7764
Additional location
10811 W 143Rd St Ste 250
Orland Park, IL 604671913
Additional location
14315 108Th Ave Ste 110
Orland Park, IL 604675701
Show 4 more locations
Additional location
15947 W 127Th St Ste B
Lemont, IL 604397421
Additional location
1890 Silver Cross Blvd Ste 540
New Lenox, IL 604519598
Additional location
222 Colorado Ave
Frankfort, IL 604231334
Additional location
2310 York St Ste 500
Blue Island, IL 604062411

Credentials & registration

NPPES · NUCC
NPI registered
October 2005 — 21 yrs on file
Profile last updated
December 20, 2025
Year of graduation
1986 — 40 yrs since
Specialty taxonomy
207RH0003X — NUCC code
State license (1)
Florida #ME127135
Medicaid
IL #036087412

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1285622621. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
212,110
Distinct HCPCS
10
Medicare allowed
$2,082,460
HCPCS Description Services Patients Avg allowed
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) 118,830 67 $0
J9263 Injection, oxaliplatin, 0.5 mg 19,200 11 $0
J9271 Injection, pembrolizumab, 1 mg 18,200 12 $54
J0897 Injection, denosumab, 1 mg 17,940 119 $22
Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units 6,240 39 $8
J1100 Injection, dexamethasone sodium phosphate, 1 mg 4,800 42 $0
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 2,424 147 $1
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count 2,339 438 $8
80053 Blood test, comprehensive group of blood chemicals 2,189 418 $10
J3475 Injection, magnesium sulfate, per 500 mg 2,098 40 $1

In context: peer comparison

Among 1 peers in this city , average services per provider: 3,787. This provider delivers 56× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,519
Transactions
49
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
AstraZeneca Pharmaceuticals LP 7 $152.58
PFIZER INC. 7 $128.39
Takeda Pharmaceuticals U.S.A., Inc. 5 $113.01
Regeneron Healthcare Solutions, Inc. 3 $102.17
Novartis Pharmaceuticals Corporation 4 $96.05
Janssen Biotech, Inc. 3 $83.04
Eisai Inc. 4 $76.81
E.R. Squibb & Sons, L.L.C. 3 $73.20
GlaxoSmithKline, LLC. 3 $64.45
Astellas Pharma US Inc 2 $53.42
Celgene Corporation 2 $44.29
ABBVIE INC. 2 $43.64
Mirati Therapeutics, Inc. 1 $42.42
Pharmacosmos Therapeutics Inc. 2 $42.36
Alexion Pharmaceuticals, Inc. 1 $31.71

By nature of payment

Food and Beverage
$1,519

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
28
Patients
0
Total drug cost
$472,438
Drug Type Claims Patients Total cost
Lenalidomide Generic 15 0 $226,771
Revlimid (Lenalidomide) Brand 13 0 $245,668

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Refat Baridi's medical specialty?
Dr. Refat Baridi practices Hematology & Oncology Physician in Woodridge, IL.
Where does Dr. Refat Baridi practice?
Dr. Refat Baridi practices at 7425 Janes Ave, Woodridge, IL 605172356. Office phone: 8153007764.
What is Dr. Refat Baridi's NPI?
Dr. Refat Baridi's National Provider Identifier (NPI) is 1285622621, issued by NPPES.
Does Dr. Refat Baridi accept Medicare assignment?
Yes. Dr. Refat Baridi accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Refat Baridi commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138); Injection, oxaliplatin, 0.5 mg (HCPCS J9263); Injection, pembrolizumab, 1 mg (HCPCS J9271). Source: CMS Medicare Physician & Other Practitioners file.